GnRH-Agonisten-Therapie bei Frauen mit Endometriose der Stadien III-IV nach rASRM-Kriterien vor reproduktionsmedizinischen Techniken (IVF / ICSI) (GARTE-Studie) - GARTE
- Conditions
- Women with endometriosis who have been diagnosed with Stages III -IV according to rASRM criteria
- Registration Number
- EUCTR2006-002547-83-DE
- Lead Sponsor
- Dr. Peter Sydow
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- Female
- Target Recruitment
- Not specified
Inclusion Criteria
women of age 18-40 with diagnosis of endometriosis stages III-IV according to rASRM criteria who had surgery during the last 3 month before beeing recruites to the study
FSH<12 IU/ml
signed informed consent
negative pregnancy test
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
pregnancy and lactation
all contraindications against tested medication
all possible interaction (e.g. allergies) with tested medication
participation in other clinical trial parallel or 8 weeks prior to this study
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method